Meta’s own research (and its use of it) has shown that it repeatedly ignores well-substantiated facts about the harms of its products. Now that Section 230 seems like a flawed shield, I fear the takeaway for other companies will be: never do the research in the first place to preserve plausible deniability. Meta has always… Continue reading Meta shares drop on fears US verdicts open door to deluge of lawsuits